Micellar-type complexes of tailor-made synthetic block copolymers containing the HIV-1 tat DNA for vaccine application

By Caputo A.   Betti M.   Altavilla G.   Bonaccorsi A.   Boarini C.   Marchisio M.   Butto S.   Sparnacci K.   Laus M.   Tondelli L.   Ensoli B.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2303-2317

Elsevier

Access to resources Recommend Favorite

Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTL

By Dominici S.   Laguardia M.E.   Serafini G.   Chiarantini L.   Fortini C.   Tripiciano A.   Brocca-Cofano E.   Scoglio A.   Caputo A.   Fiorelli V.   Gavioli R.   Cafaro A.   Ensoli B.   Magnani M.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 2082-2090

Elsevier

Access to resources Recommend Favorite

Identification of a peptide capable of inducing an HIV-1 Tat-specific CTL response

By Morris C.B.   Thanawastien A.   Sullivan D.E.   Clements J.D.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 12-15

Elsevier

Access to resources Recommend Favorite

Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site

By Bin W.   Dang K.   Agadjanyan M.G.   Srikantan V.   Feng L.   Ugen K.E.   Boyer J.   Merva M.   Williams W.V.   Weiner D.B.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 821-825

Elsevier

Access to resources Recommend Favorite

Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses

By Debin A.   Kravtzoff R.   Santiago J.V.   Cazales L.   Sperandio S.   Melber K.   Janowicz Z.   Betbeder D.   Moynier M.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2752-2763

Elsevier

Access to resources Recommend Favorite